Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

133.45 -1.03 (-0.77%)
Streaming Delayed Price Updated: 2:50 PM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
News headline image
ILLUMINA INC (NASDAQ:ILMN) Shows Bull Flag Setup Ahead of Potential Breakout ↗
ILLUMINA INC (ILMN) shows a strong technical breakout setup with a high trend rating and a defined bull flag pattern, suggesting a potential entry point for momentum traders. 
Via Chartmill
News headline image
Is Illumina Inc Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
What If the Future Looked Back at Us? A New Sci-Fi Project Explores Gender, Power, and Perspective
NEW YORK, N.Y., Dec. 19, 2025 (SEND2PRESS NEWSWIRE) -- What if men had to prove they were marriage material? What if men were judged by their biceps and facial symmetry? What if men needed to smile... 
Via Send2Press
News headline image
Wix Stock Tumbles 50% in One Year — But Is Vibe-Coding AI Platform Base44 the Reason This Fund Is Doubling Down? ↗
A major hedge fund just made a beaten-down tech name its largest bet. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Why One Fund Dumped $74 Million of Bank OZK Stock Despite a Record $180.5 Million Earnings ↗
Why would a fund walk away from a bank that just posted record earnings? 
Via The Motley Fool
News headline image
This Fintech Stock Is Down 70% — But a Hedge Fund Just Boosted Its $66 Million Stake ↗
A major hedge fund just made a bold bet on a fintech name that’s quietly turning its fundamentals around — here’s what they’re likely seeing. 
Via The Motley Fool
News headline image
EPAM Stock Is Down 15% This Past Year — But This Fund Is Betting $146 Million on a Turnaround ↗
EPAM’s latest results suggest its long slump may be out of sync with its fundamentals — here’s why a major hedge fund just doubled down. 
Via The Motley Fool
News headline image
popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery
Cambridge, MA & Barcelona, Spain – November 25, 2025 – A groundbreaking artificial intelligence model, popEVE, developed by a collaborative team of researchers from Harvard Medical School and the... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Illumina Inc (NASDAQ:ILMN) Presents a Compelling Case for Value Investors ↗
Illumina (ILMN) offers strong value with low valuation metrics, high profitability, and solid financial health, making it an intriguing stock for value investors. 
Via Chartmill
News headline image
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 per share. This was partly due to its solid quarterly results, and the... 
Via StockStory
News headline image
3 Unpopular Stocks with Warning Signs
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
1 Momentum Stock with Promising Prospects and 2 We Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
Cisco, Morgan Stanley, FTAI Aviation And A Health Care Stock On CNBC's 'Final Trades' ↗
On CNBC's "Halftime Report," Cerity Partners' Jim Lebenthal named Cisco Systems as his final trade and that the fundamentals justify it. 
Via Benzinga
News headline image
Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes
Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025.... 
Via MarketMinute
Topics Artificial Intelligence Economy Law Enforcement
News headline image
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
1 Profitable Stock Worth Investigating and 2 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
5 Revealing Analyst Questions From Illumina’s Q3 Earnings Call
Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit expectations, with positive market reaction following the report. Management... 
Via StockStory
Topics Earnings
News headline image
10x Genomics Earnings: What To Look For From TXG
Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know. 
Via StockStory
News headline image
PacBio Earnings: What To Look For From PACB
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
Illumina (ILMN) Stock Trades Down, Here Is Why
Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.4% in the afternoon session after its negative momentum continued as Barclays maintained its Underweight recommendation on the stock. The... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025. 
Via Benzinga
Topics ETFs
News headline image
Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗
Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results. 
Via Benzinga
News headline image
Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Illumina (ILMN) Stock Is Up Today
Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year... 
Via StockStory
Topics Economy Government World Trade
News headline image
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars ↗
Illumina shares rise after posting Q3 earnings and revenue above estimates, raising 2025 guidance and showing growth in clinical sequencing markets. 
Via Benzinga
News headline image
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance
Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share... 
Via StockStory
News headline image
Illumina Inc (NASDAQ:ILMN) Surpasses Profit Expectations in Q3 2025, Sparking 8.6% Stock Rally ↗
Illumina (ILMN) Q3 2025 earnings beat profit estimates, sending shares up 8.6%. Strong EPS of $1.34 on flat revenue impressed investors. 
Via Chartmill
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.